Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy
Condition(s):SchizophreniaLast Updated:September 16, 2008Terminated
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:September 16, 2008Terminated
Condition(s):Psychosis; AggressionLast Updated:October 13, 2006Terminated
Condition(s):Delirium; Cognition DisordersLast Updated:January 29, 2016Completed
Condition(s):Delirium; Cognitive ImpairmentLast Updated:August 17, 2018Completed
Condition(s):Schizophrenia and Disorders With Psychotic FeaturesLast Updated:February 16, 2017Unknown status
Condition(s):SchizophreniaLast Updated:March 22, 2007Completed
Condition(s):Cocaine-Related Disorders; Substance-Related DisordersLast Updated:January 12, 2017Completed
Condition(s):Bipolar DisorderLast Updated:December 28, 2010Completed
Condition(s):Schizophrenia; Psychotic DisordersLast Updated:February 11, 2011Completed
Condition(s):Bipolar DisorderLast Updated:April 10, 2008Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.